5th European CAR T-cell Meeting

The European Hematology Association (EHA) and the EBMT are excited to announce the 5th edition of the jointly organized European CAR T-cell Meeting. 

Dates: February 9-11, 2023
Location: Rotterdam, the Netherlands
Format: Hybrid
 Michael Hudecek & Anna Sureda

Registration is closed

The meeting will cover a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The programme will bring you all the latest in CAR T and will even bring in the first ever reported clinical data. Join the meeting to be able to hear the latest developments and to have the chance to discuss this important topic with both experts and your peers.


This is a Hybrid meeting, which can be attended physically or virtually. The emphasis lies on the physical participation in the programme, but most sessions will be livestreamed via a virtual platform for those that can only follow the programme remotely.

Target audience

The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organization representatives.


Postillion Hotel & Convention Centre WTC Rotterdam
Beursplein 37
3011 AA Rotterdam
The Netherlands

Meeting opening hours:

Thursday, February 9 12:00 - 20:30
Friday, February 10 08:00 - 18:30
Saturday, February 11 07:30 - 15:00


The program will cover various CAR T-cell related topics and will include key note lectures, interactive debate sessions and more. To see the developing program please see the meeting program page

Scientific Program Committee

The meeting is led by A Sureda and M Hudecek, in close collaboration with the Scientific Program Committee (SPC). Together they have created the program and helped select speakers. The members are:

  • Ibrahim Yakhoub-Agha (France)
  • Annalisa Ruggeri (Italy)
  • Raffaella Greco (Italy)
  • Natacha Bolaños (Spain)
  • Michelle Kenyon (United Kingdom)
  • Valentin Ortiz Maldonado (Spain)
  • Claire Roddie (United Kingdom)
  • Maria Themeli (The Netherlands)
  • Ulrich Jäger (Austria)
  • Solène Clavreul (France)
  • Erik Aerts (Switzerland)
  • Eleni Gavriilaki (Greece)

Abstract and Case submission

Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers. 

Introduced in 2021, we are excited to announce that there will Best Abstract Awards again this year. Submissions will be reviewed by the Scientific Programme Committee. Three winners will be selected and each receive €10.000 and the opportunity to present their abstract in one of  the Best Abstracts Sessions. This award is sponsored by EHA, EBMT, Gilead and Kite Oncology.

Abstract submission is now closed.


Registration is closed. For an overview of the registration fees and deadlines, please see the registration and accommodation page. 


This meeting is supported by:

Supreme Partners:


Meeting Partner:

Meeting Contributor:



Partner Project:

Media partner:

There are various opportunities to support this educational course. For more information, please send an email to sponsorship@ehaweb.org or fundraising@ebmt.org to indicate your interest.


EBAH accredited stamp DEF2


EBAH CME accreditation

This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.